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42* Do false positive test results for newborn screening for cystic
ﬁbrosis lead to long term parental anxiety?
A.M. Vernooij-van Langen1,2, S.J. Reijntjens2, S.M. van der Pal3, J.G. Loeber1,
E. Dompeling4, J.E. Dankert-Roelse2, CHOPIN Study Group. 1RIVM, Bilthoven,
Netherlands; 2Atrium Medical Center, Heerlen, Netherlands; 3TNO Quality of
Life, Leiden, Netherlands; 4Maastricht University Medical Center, Maastricht,
Netherlands
Objective: to evaluate whether parental anxiety induced by a false positive screen-
ing test result disappears after six months and to assess whether a special program to
inform the parents prior and during the screening procedure prevents or diminishes
parental anxiety.
Study design: Prospective controlled study assessing the long term effects of false-
positive test results of newborn screening for CF on parental anxiety and stress by
means of questionnaires sent to parents of 106 infants with a false positive newborn
screening test and of 318 randomly selected infants with a true negative screening
test. Semi-structured in-depth interviews with 25 parents of the false-positive group.
Results: Parents showed negative feelings after being informed about the positive
screening test result which increased signiﬁcantly with the time gap between the
news of the test result and the follow-up test. After conﬁrmation their child was
healthy and not suffering from CF, they felt reassured in most cases. After six
months no difference in anxiety levels between both groups of parents was found.
Well-informed parents in the false positive group experienced less stress than less
well informed parents. Parents opinion of their infant’s health was not different
between the false-positive and control group.
Conclusions: Initial anxiety after a positive screening test result increases strongly
with a delay in the follow-up procedure, but false positive test results for newborn
screening for CF do not seem to cause long-term parental anxiety. Well-informed
parents showed lower stress levels.
43 Atypical forms of cystic ﬁbrosis (CF): The emerging diagnostic
challenge for diagnosing CF in children and adolescents with a
single-organ involvement
F. Alghisi1, E. Montemitro1, S. Bella1, V. Lucidi1. 1Bambino Gesu` Children’s
Hospital − IRCCS, Rome, Italy
Objectives: Patients with a non-classic form of Cystic Fibrosis (CF) may present
a single organ involvement. They have non-diagnostic sweat chloride test values
and/or they are carrier of two not clearly demonstrated CF-causing mutations. The
aim of our study was to identify atypical forms of CF in a pediatric population
affected by recurrent pancreatitis.
Methods: We enrolled 105 consecutive young patients (53M, mean age at diagnosis
8.9±5.4 yrs, range 4 months − 18 yrs) affected by recurrent pancreatitis of several
etiologies. All patients were tested for CF by a sweat chloride test and a CFTR
gene sequencing was done for most of them. A pathological sweat test revealed
classic CF at its onset in two patients. Border-line sweat chloride values were
found in 8 (7.6%) patients. We detected CFTR gene mutations in 35.5% (22/62) of
patients. Only two patients with border-line sweat chloride values had two CFTR
gene mutations (1 surely CF-causing); one of them was diagnosed as having classic
CF when he developed bronchiectasis during clinical follow-up.
Conclusions: We observed a high percentage of patients (7.6%) with borderline
sweat chloride values. Only two of these patients had 2 FTR gene mutations (but
only one known CF-causing mutation); clinical follow-up was determinant for
diagnosing CF in one of them. We also identiﬁed 8 patients carrying two CFTR
gene mutations but they had a negative sweat test. These patient groups currently
represent a challenge for a correct CF diagnosis. In the absence of sure diagnostic
investigations, only clinical features and follow-up may lead clinicians to conﬁrm
or, ultimately, to exclude CF.
44* Difﬁcult counseling situations − lessons from a cystic ﬁbrosis
expertise laboratory
M. Tzetis1, M. Poulou1, E. Kanavakis1. 1University of Athens, Medical Genetics,
Athens, Greece
Cystic Fibrosis is the most common autosomal recessive disorder. The carrier
frequency in Greece is estimated at 5% of general population. The Department
of Medical Genetics, University of Athens has been offering molecular analysis of
the CFTR gene since 1992. During that time we have screened more than 10.500
members of the general population, 700 patients of Greek origin and done more
than 500 prenatal diagnoses.
Due to the great molecular heterogeneity of the Greek population, the four most
common mutations [p.F508del (54.6%), c.621+1G>T (6.22%), p.G542X (3.66%)
and p.N1303K (2.39%)] cover only 66.9% of the mutations found. That signiﬁes
that a large number of CF causing alleles are found rarely or even in single families.
The low incidence of these rare mutations as well as novel mutations which can be
only be assessed through in-silico analysis, pose a problem in genetic counseling.
Can we safely assign a “carrier status” or inform for the outcome of a pregnancy
when the couple carries such mutations?
In our laboratory we have also been facing dilemmas in cases where known and
functionally assessed disease causing mutations, have been found in homozygosity
in healthy individuals, disease causing mutations have been found in compound
heterozygotes with no CF phenotypic features and in cases where we have to counsel
couples carrying a novel and a disease causing mutation.
We will be presenting these special cases and discussing the difﬁculties in genetic
counseling.
45* Meconium ileus in cystic ﬁbrosis newborn screening (CF NBS)
D. Sands1, K. Zybert1, M. Mielus1, M. Ołtarzewski2, K. Walicka1, R. Piotrowski1.
1Institute of Mother and Child, Pediatric Department, Warsaw, Poland; 2Institute
of Mother and Child, Screening Department, Warsaw, Poland
Objectives: Comparison between patients with Meconium ileus (MI) and without
MI (non-MI) diagnosed in CF NBS.
Methods: Groups of MI and non-MI patients diagnosed in CF NBS with the same
age, gender and CFTR mutations were analyzed. Birth weight, age at diagnosis,
IRT, sweat test values and evaluation of nutritional status in the 1st year of life
were collected.
Results: From Sept. 2006 to the end of August 2010 there were 430 979 newborns
screened. CF was conﬁrmed in 80 cases. 13 patients with MI and 13 non-MI
were analyzed. Both groups consisted of 6 F508del homozygotes; 5 F508del
hetertozygotes and 2 non-F508del heterozygotes. All patients were pancreatic
insufﬁcient. Average age at diagnosis in MI group was similar to non-MI patients (c.
6 weeks). The mean birth weight and average sweat test values showed no signiﬁcant
differences between the groups. The mean IRT for the group MI (410.54±363.35)
was signiﬁcantly lower than in the non-MI patients (749.15±367.46) (p = 0.0266).
Average SDS body weight (−1.18±0.81v 0.04±0.81; p = 0.0008) and SDS height
(−1.18±0.81 v 0.04±0.81; p = 0.0008) in the 1st year of life were considerably
reduced in MI patients. Thus, IWH% in MI patients (90.38±8.4) was lower than
for the non-MI group (103.15±11.22) p = 0.0031.
Conclusion:
1. Lower (nearer to normal) IRT values in MI patients might lead to diagnostic
difﬁculties. Neonatal teams should mark the importance of reporting MI cases
to the Screening Centre.
2. Worse somatic development of MI patients after the 1st year of life, despite
early diagnosis, underlines the importance of intensive nutritional monitoring
and treatment of CF patients with MI.
